InvestorsHub Logo
Followers 4
Posts 1608
Boards Moderated 0
Alias Born 09/07/2006

Re: Virgilio post# 141042

Tuesday, 10/31/2017 5:56:13 AM

Tuesday, October 31, 2017 5:56:13 AM

Post# of 701958
By the way, the slide itself exactly says "progression/recurrence then other". To be more precise I believe that this "subgroup" of non-treated patients is inclusive of those who didn't want to have Dcvax after PFS and decided for other treatments, those who were unfortunately too sick to start Dcvax and probably passed by shortly thereafter, and possibly even a couple of patients who were lost to follow-up (even though there might be zero of these patients in this subgroup). IMO there's no way to know how many are in the subgroup above and how many are in the subgroup of those who have placebo treatment still ongoing. IMO, the fact that about 90% of patients as of 06/17 were exposed to Dcvax doesn't help much because in my opinion it could be that those not exposed, 10% or 33 patients, could be those who had "progression/recurrence then other" and the "placebo treatment still ongoing" subgroup right now could even be zero.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News